Express Pharma Private Limited
About Express Pharma Private Limited
Data last updated:
Express Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 16 March 2005.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC152004. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Jayesh Pravin Pancholi and Karl Keki Surty.
Its last annual general meeting (AGM) was held on 23 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Mumbai, Maharashtra.
Company details
CIN history
Express Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230MH2005PTC152004, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2005PTC152004 | Current |
| U24230MH2005PLC152004 | Previous |
| L24230MH2005PLC152004 | Previous |
Contact details
Express Pharma Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressSimplex Mill Compound 1st Floor 30 Keshavrao Khadye Marg Sant Gadge Mah, Araj Chowk, Mumbai, Maharashtra, India – 400011
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Express Pharma Private Limited
FY 2024 filings availableExpress Pharma Private Limited reported revenue of ₹980 (down 99% YoY) for FY 2015.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 77% over three years, including a 99% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | ₹980 |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Express Pharma Private Limited, buy the company report.
Board of directors of Express Pharma Private Limited
Express Pharma has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayesh Pravin Pancholi Also directs: Speedking Pharma Private Limited | Director | 10 Feb 2020 | 6 Years 8 Months | As last reported |
| Karl Keki Surty Also directs: Speedking Pharma Private Limited | Director | 19 Jul 2021 | 5 Years 3 Months | As last reported |
| Nirav Niranjan Shah Also directs: Jet Pharma Private Limited, Zivo Enterprise Private Limited, Luckystar Distributors Private Limited and 2 more | Director | 16 Mar 2005 | 21 Years 7 Months | As last reported |
| Devina Nirav Shah Also directs: Jet Pharma Private Limited, Luckystar Distributors Private Limited, Speedking Pharma Private Limited and 1 more | Director | 01 Nov 2017 | 8 Years 11 Months | As last reported |
Legal cases
No court or tribunal cases involving Express Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Express Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Express Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Express Pharma Private Limited, buy the company report.
Recent activity
Express Pharma Private Limited has 11 board changes on record since 2005: 4 appointments and 7 cessations. The latest: Karl Keki Surty ceased to be Additional Director on 26 Nov 2021.
2 earlier events are in the company report.
Frequently asked questions
Express Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Express Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in wholesale, within the trading industry. It was incorporated on 16 March 2005 and is registered under CIN U24230MH2005PTC152004. The company has been struck off by the Registrar of Companies and is no longer operational.
Express Pharma had 4 directors:
- Jayesh Pravin Pancholi - Director
- Karl Keki Surty - Director
- Nirav Niranjan Shah - Director
- Devina Nirav Shah - Director
The CIN (Corporate Identification Number) of Express Pharma is U24230MH2005PTC152004. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Express Pharma is at Simplex Mill Compound 1st Floor 30 Keshavrao Khadye Marg Sant Gadge Mah, Araj Chowk, Mumbai, Maharashtra, India – 400011.
Express Pharma was incorporated on 16 March 2005. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Express Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 23 September 2024. Year-wise statements from 2015 are in the company report.
No. Express Pharma has 1 GST registration on record and it is cancelled or inactive.
Express Pharma operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
Karl Keki Surty ceased to be Additional Director on 26 Nov 2021. Karl Keki Surty was appointed as Director on 19 Jul 2021. Himanshu Balmukund Trivedi ceased to be Additional Director on 30 Dec 2020. Express Pharma has 11 board changes on record in total.